Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
News Briefing channel feed
J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund
10 months ago
SpringWorks gets priority review; Botox competitor data; Hyundai's Covid treatment; Arcus takes a loan
10 months ago
Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug
10 months ago
Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio
10 months ago
Novo's innovation hub expands to Bay Area; SIGA's new Tpoxx order
10 months ago
Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer
10 months ago
Kymera seeks to raise $225M; Adcendo, Multitude's new ADC deal
10 months ago
Avidity’s upsized $345M offering; Janus Henderson’s new $150M biotech fund
10 months ago
AN2’s poison pill; Pfizer shares promising mid-stage data for flu shot
10 months ago
Lyra pauses work on sinusitis drug; Pathos AI licenses a new asset
10 months ago
Another offering for Avidity; Galera shuts down
11 months ago
Kyverna shares safety data for CAR-T; Evotec gets $75M milestone
11 months ago
Tenax raises $100M; Sanofi buys into MeiraGTx
11 months ago
A CAR-T deal in China; Zevra’s $60M offering
11 months ago
Roivant to 'unveil' pipeline addition next month; Bavarian Nordic gets $156M from US
11 months ago
Stoke Therapeutics’ partial hold lifted; Recursion gets $30M from Roche
11 months ago
BioCryst culls Factor D inhibitor; Elevation Oncology’s stock plummets
11 months ago
Layoffs at Sumitomo; Galderma and L’Oréal strike a deal
11 months ago
Blueprint ups Ayvakit guidance; Aurinia to advance autoimmune disease asset
11 months ago
Ideaya and Biocytogen ink $400M+ deal; Daiichi spends more on superstar ADCs
11 months ago
Day One's $175M PIPE; Pinetree raises $17M in Series A
11 months ago
Collegium pays $525M to buy ADHD company; FDA delays Syndax decision
11 months ago
ProMIS announces PIPE up to $122M; Confo raises €60M in Series B
11 months ago
Galderma deprioritizes study for IL-31 drug; UCB stops work in rare encephalitis
11 months ago
First page
Previous page
6
7
8
9
10
11
12
Next page
Last page